Transcriptome Biomarker Validation
Transcriptome Biomarker Validation is a methodological framework within transcriptomic profiling that systematically assesses the reliability, reproducibility, and clinical or biological relevance of transcriptome-derived biomarkers to confirm their utility in diagnosing, prognosing, or monitoring disease states.
36
Publications
4.2K
Citations
473
Authors
198
Institutions
Publications per year
2017–2026
26
Parents
36
Kelly G. Paulson, Jayasri G. Iyer, Andrew Tegeder et al. · Journal of Clinical Oncology · 2011 · 296 citations · Full text
Medicine, Cancer Biology, Oncology +17
Jóhann E. Guðjónsson, Jun Ding, Andrew Johnston et al. · Journal of Investigative Dermatology · 2010 · 234 citations · Full text
1–5 of 36
473
2
h-index
2
h-index
2
h-index
Amsterdam University Medical Centers, Netherlands
2 publications · 131 citations
2
h-index
2
h-index
1–5 of 473
198
Harvard University
Cambridge, United States
3 h-index
7 publications
457 citations
Massachusetts General Hospital
Boston, United States
3 h-index
21 publications
6K citations
Stanford University
Stanford, United States
3 h-index
35 publications
3.9K citations
Stanford Medicine
Stanford, United States
3 h-index
18 publications
2.3K citations
Amsterdam University Medical Centers
Amsterdam, The Netherlands
2 h-index
18 publications
1.8K citations
University of Oxford
Oxford, United Kingdom
2 h-index
2 publications
39 citations
University College London
London, United Kingdom
2 h-index
15 publications
345 citations
Duke Medical Center
Durham, United States
2 h-index
5 publications
180 citations
1–8 of 198
3 publications · 142 citations
3
h-index
3 publications · 95 citations
3
h-index
1 publications · 49 citations
1
h-index
1 publications · 296 citations
1
h-index
1 publications · 11 citations
1
h-index
1–5